{"title":"扩大精准肿瘤学知识库的应用","authors":"Sarah Suehnholz, Debyani Chakravarty","doi":"10.1038/s41568-025-00846-3","DOIUrl":null,"url":null,"abstract":"Precision oncology knowledge bases currently provide cancer clinicians with a point-of-care interpretation of the therapeutic actionability of somatic genomic sequencing results. Here, we discuss key deficiencies in these knowledge bases that present as opportunities for the next generation of data annotation. Precision oncology knowledge bases provide cancer clinicians with a point-of-care interpretation of the therapeutic actionability of clinical genomic sequencing results. These knowledge bases are now positioned to expand beyond the annotation of individual somatic molecular alterations, however, important gaps remain. Here, Suehnholz and Chakravarty discuss key deficiencies in current precision oncology knowledge bases that present opportunities for the next generation of data annotation.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"46 1","pages":""},"PeriodicalIF":66.8000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expanding the utility of precision oncology knowledge bases\",\"authors\":\"Sarah Suehnholz, Debyani Chakravarty\",\"doi\":\"10.1038/s41568-025-00846-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Precision oncology knowledge bases currently provide cancer clinicians with a point-of-care interpretation of the therapeutic actionability of somatic genomic sequencing results. Here, we discuss key deficiencies in these knowledge bases that present as opportunities for the next generation of data annotation. Precision oncology knowledge bases provide cancer clinicians with a point-of-care interpretation of the therapeutic actionability of clinical genomic sequencing results. These knowledge bases are now positioned to expand beyond the annotation of individual somatic molecular alterations, however, important gaps remain. Here, Suehnholz and Chakravarty discuss key deficiencies in current precision oncology knowledge bases that present opportunities for the next generation of data annotation.\",\"PeriodicalId\":19055,\"journal\":{\"name\":\"Nature Reviews Cancer\",\"volume\":\"46 1\",\"pages\":\"\"},\"PeriodicalIF\":66.8000,\"publicationDate\":\"2025-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Reviews Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41568-025-00846-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41568-025-00846-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Expanding the utility of precision oncology knowledge bases
Precision oncology knowledge bases currently provide cancer clinicians with a point-of-care interpretation of the therapeutic actionability of somatic genomic sequencing results. Here, we discuss key deficiencies in these knowledge bases that present as opportunities for the next generation of data annotation. Precision oncology knowledge bases provide cancer clinicians with a point-of-care interpretation of the therapeutic actionability of clinical genomic sequencing results. These knowledge bases are now positioned to expand beyond the annotation of individual somatic molecular alterations, however, important gaps remain. Here, Suehnholz and Chakravarty discuss key deficiencies in current precision oncology knowledge bases that present opportunities for the next generation of data annotation.
期刊介绍:
Nature Reviews Cancer, a part of the Nature Reviews portfolio of journals, aims to be the premier source of reviews and commentaries for the scientific communities it serves. The correct abbreviation for abstracting and indexing purposes is Nat. Rev. Cancer. The international standard serial numbers (ISSN) for Nature Reviews Cancer are 1474-175X (print) and 1474-1768 (online). Unlike other journals, Nature Reviews Cancer does not have an external editorial board. Instead, all editorial decisions are made by a team of full-time professional editors who are PhD-level scientists. The journal publishes Research Highlights, Comments, Reviews, and Perspectives relevant to cancer researchers, ensuring that the articles reach the widest possible audience due to their broad scope.